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ORIGINAL PAPER

EXPLORATION OF THE RELATIONSHIP OF SLEEP QUALITY
IN PATIENTS WITH DIABETIC RETINOPATHY,
VILLAHERMOSA TABASCO
EXPLORACIÓN DE LA RELACIÓN DE LA CALIDAD DEL SUEÑO EN PACIENTES CON RETINOPATÍA
DIABÉTICA, VILLAHERMOSA TABASCO.
Tirsa Abisag Espinoza-Anguiano1,a, GJ Avilés-Rodriguez 2,b, José Ricardo Espinoza-Vargas3,c

ABSTRACT
Introduction: In recent decades, there has been growing evidence suggesting that too little or too much sleep is
associated with adverse health outcomes, including type 2 diabetes. There is a close association between diabetes
and diabetic retinopathy (DR), so it is reasonable to assume that sleep may also have associations with DR.
Objective: To explore the relationship between the perception of sleep quality and the degree of diabetic
retinopathy in patients with type 2 Diabetes Mellitus treated at a 3rd level ophthalmological care service. Results:
Signi cant correlations were found in: diastolic and systolic blood pressure (0.429), triglycerides and total
cholesterol (0.707), glycosylated hemoglobin (HbA1c) and glycemia (0.561), Epworth sleepiness scale (ESS Score)
and age (0.394) , ESS Score and weight (0.365), extended STOP questionnaire (Stop Bang) and age (0.317), Stop
Bang and weight (0.579), Stop Bang and ESS Score (0.452), insomnia severity index (ISI Score) and Stop Bang (0.460).
Although the reduced sample size limited the results in the associations by subgroups in the study, a trend towards
an elevation of the ESS score can be seen in the subgroup of patients who reported sleeping 8 hours or more.
Conclusions: Although the trends are not statistically signi cant, the authors consider that this nding is
congruent with the state of the art on the subject of sleep and metabolic condition of retinopathic diabetic patients
(increased trend of ESS score reported in the subgroup of 8 or more hours sleep), it will be necessary to explore this
phenomenon in more detail and in a larger number of patients.
Keywords: Sleep, Sleepiness, Diabetes Mellitus, Diabetic Retinopathy (Source: MeSH NLM).

RESUMEN
Introducción: En las últimas décadas, ha habido una creciente evidencia que sugiere que dormir muy poco o
demasiado se asocia con resultados adversos para la salud,incluida la diabetes tipo 2. Existe una estrecha
asociación entre la diabetes y la retinopatía diabética (RD), por lo que es razonable suponer que el sueño también
puede tener asociaciones con la RD. Objetivo: Explorar la relación entre la percepción de la calidad del sueño y el
grado de retinopatía diabética en pacientes con Diabetes Mellitus tipo 2 atendidos en un servicio de atención
oftalmológica de 3er nivel. Resultados: Se encontraron correlaciones signi cativas en: Presión arterial diastólica y
sistólica (0.429), triglicéridos y colesterol total (0.707), hemoglobina glicosilada (HbA1c) y glicemia (0.561), escala
de somnolencia de Epworth (ESS Score) y edad (0.394), ESS Score y peso (0.365), cuestionario STOP extendido (Stop
Bang) y edad (0.317), Stop Bang y peso (0.579), Stop Bang y ESS Score (0.452), índice de severidad del insomnio (ISI
Score) y Stop Bang (0.460). Aunque el tamaño de muestra reducido limitó los resultados en las asociaciones por
subgrupos en el estudio, se puede apreciar una tendencia hacia la elevación del ESS score en el subgrupo de
pacientes que reportaron dormir 8 horas o más. Conclusiones: Aunque las tendencias no son estadísticamente
signi cativas, los autores consideran que este hallazgo es congruente con el estado del arte en el tema de sueño y
condición metabólica de pacientes diabéticos retinópatas (tendencia elevación de ESS score reportado en el
subgrupo de 8 o más horas de sueño), será necesario explorar con más detalle y en una mayor cantidad de
pacientes éste fenómeno.
Palabras clave: Sueño; somnolencia; diabetes mellitus; retinopatía diabética (Fuente: DeCS BIREME).
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INTRODUCTION
Sleep is a biobehavioral phenomenon regulated by
circadian, homeostatic, and neurohormonal processes.
(1) . A highly signi cant factor can be derived from the
eﬀects of sleep duration: the individual's perception of
their sleep quality, that is, the assessment on whether
the time the person slept produced a restorative eﬀect.
Lack of sleep exerts deleterious eﬀects on metabolic,
endocrine, and immune pathways (1) . In recent decades,
there has been growing evidence suggesting that too
little and too much sleep is associated with adverse
health outcomes, including total mortality ( 2 , 3 ) ,
cardiovascular disease ( 3 , 5 , 7 ) , type diabetes 2 ( 8 ) ,
hypertension(3,9) , and respiratory disorders, obesity in
children and adults (10) , and self-rated poor health (11) .
The inability to maintain a normal sleep pattern may
involve more than feeling tired the next day, as
metabolic control, glucocorticoid production, and
blood glucose control are aﬀected (12) . In recent years, it
has been increasingly shown that suboptimal sleep
duration and quality (secondary to the changes
demanded by a modern 24-hour society) is signi cantly
associated with diabetes mellitus, insulin resistance (IR),
and poor glycemic control (13,15) .
The mechanisms that relate short or long sleep duration
to the prevalence and severity of DR are not fully
understood, although some postulations can be made.
Sleep deprivation can be detrimental with respect to
DR, as it has been associated with increased levels of
ghrelin and leptin (which increases hunger and
decreases satiety, and tips the energy balance towards
excess (16), as well as insulin resistance and worse
glycemic control (14,15) .
A pro-in ammatory state induced by sleep deprivation
is another possible explanation, since in ammatory
biomarkers have also been related to DR (17,18) . Rather,
sleep disruption may be a consequence of DR.
Nighttime melatonin levels were shown to be altered
(19)
. In addition, prolonged sleep duration may promote
retinal hypoxia, as rod photoreceptors consume large
amounts of energy during darkness by maintaining
dark currents, increasing retinal oxygen tension (20) . It
h a s b e e n s u g g e s t e d t h a t n o c t u r n a l ox yg e n
desaturation may induce the expression of vascular
endothelial growth factor (21) , which is known to
promote DR.
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The present research aims to explore the relationship
between the perception of sleep quality and the degree
of diabetic retinopathy in patients with type 2 Diabetes
Mellitus treated in an ophthalmological care service.

METHODS:
Study type and design
A cross-sectional correlation study was conducted in a
specialized ophthalmology center in Mexico.

Population and sample
We worked with patients older than 18 years with a
diagnosis of DM who attend the consultation of the
Ophthalmology Service of the Dr. Julian A. Manzur
Ocaña ISSET Medical Specialties Center, in the city of
Villahermosa, Tabasco, Mexico in the period between
15 March to April 15, 2021.

Variables and instruments
Diagnosis of diabetes was de ned by a fasting glycemia
greater than 126 mg / dl (7.0 mmol / L) (22), self-report of
the diagnosis, previous diagnosis in electronic record,
use of hypoglycemic drugs or insulin.
Regarding the evaluation of DR: the ophthalmological
examination included visual acuity for each separate
eye using the Snellen chart of 11 lines with letter
optotypes (categorized from 20/20 to no perception of
NPL light) (23) ; slit lamp biomicroscopy, intraocular
pressure with integrated tonometer (SL-D701 Topcon)
and dilated fundus examination with revision of the
vitreous and peripheral retina.
The DR diagnosis was evaluated during funduscopy
and was considered present or absent according to the
criteria and consensus of the International Retinopathy
and Diabetic Macular Edema Severity Scale (24) , which
has been assumed by the American Academy of
Ophthalmology. The following severity levels were
considered:
1. No apparent retinopathy (DNR) where no clinical
alterations are found, although there may be ndings
by angiography
2. M ild non-proliferative DR (RDNPL) where
microaneurysms are present.
3. Moderate non-proliferative DR (RDNPM) adds any
lesion in addition to the microaneurysms (spot or ame
hemorrhages, cottony exudates, edema, tortuosity of
the vessels)
4. Severe non-proliferative RD (RDNPS) presents any of
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the following: More than 20 retinal hemorrhages in
each of the 4 quadrants, venous tortuosity in 2 or more
quadrants, intraretinal microvascular abnormalities in
one or more quadrants.
5. Proliferative DR (PDR) where neovascularization and /
or vitreous or preretinal hemorrhage occurs.
After consultation with the ophthalmology service and
for statistical purposes of our study, the following
recategorization was carried out:
Category 1: NRD and RDNPL (null or minimal
intervention).
Category 2: RDNPM and RDNPS (laser intervention).
Category 3: PDR (surgical intervention and / or
antiangiogenic drugs).
Regarding the interviews and questionnaires related to
sleep: the variables related to sleep were collected
directly and verbally by the researcher applying the
following validated surveys in Spanish.
The Epworth Sleepiness Scale (ESE) is widely used for
subjective assessment of sleepiness; It is useful to assess
the propensity to fall asleep in eight situations, most of
them monotonous and some more sopori c than
others. The subject responds to each item on a scale of

Hypopnea Syndrome (OSAHS) are identi ed when at
least two (STOP) or three (STOP-Bang) questions are
answered aﬃrmatively (26) .
The Insomnia Severity Index (ISI) is a self-report that
assesses the perception of sleep in relation to daytime
performance. It comprises ve items on the severity of
the sleep onset disorder, sleep maintenance and
problems waking up in the morning, as well as the
interference with daytime functioning and the degree
of dissatisfaction with the current sleep pattern.
In the version of each of the 5 items, it is evaluated on a
5-point scale that consists of: “0 = nothing; 1 = a little; 2 =
something; 3 = a lot; 4 = very much ”. With a result of 0 to
28.
In the case of the Sierra JC version (27), this instrument
was developed with the aim of creating a short
questionnaire to assess the severity of the day and night
components of insomnia. It is made up of 7 items that
assess the nature, severity and impact of insomnia. It is
answered with a LIKERT-type scale that goes from 0 to 4,
taking into account the last month.
For its correction, a total score is obtained that ranges
between 0 and 28. The proposed cut-oﬀ points of the
original version are:
- 0-7: no insomnia
- 8-14: insomnia below threshold
-15-21: clinical insomnia of moderate severity
-22-28: severe clinical insomnia (18) .

0-3, where 0 means zero probability of falling asleep
and 3 high probability. The sum of the scores on each
item provides the total score, with a range of 0-24. A
total score of less than 10 is considered normal, 10-12 as
indicative of marginal sleepiness and above 12
suggestive of excessive sleepiness (25) .
The STOP questionnaire consists of four questions that
assess the presence of intense snoring, daytime
sleepiness or fatigue, apneas presented during sleep,
and high blood pressure. In the extended model, STOPBang, four additional parameters are incorporated: age,
gender, body mass index, and neck circumference. The
answers to the questions of both questionnaires were
designed in a simple Yes / No format and the scores
uctuate between 0 and 4 or 8 points, respectively.
Subjects at high risk for Obstructive Sleep Apnea /

In addition to the data collected in the surveys, a
questionnaire was applied with the following items:
age (in years), gender (male-female), hours of sleep
(number of hours), years of evolution of diabetes, level
of education (none , primary, secondary, preparatory,
university), smoking (absent-present) use of insulin
(yes-no), diagnosis of hypertension (yes-no and how
many years of evolution) and pharmacological
treatment of the same (yes-no), as well as previous
procedures for each eye.
Regarding the evaluation of other biomarkers: blood
pressure was measured in mm / hg using a digital
baumanometer (Omron HEM 6123), weight and height
using a wall scale (Hergom Medical), body mass index
(BMI) was determined Using the formula: weight
between age in square meters (kg / m2) and obesity was
de ned as a BMI greater than 27.5 kg / m2.
The values of total cholesterol (mg / dl), triglycerides
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(mg / dl) and HbA1c (%) were taken from the most
recent reports of the electronic le.

signi cant variables in the previous steps strati ed by
number of hours of sleep.

The values of total cholesterol (mg / dl), triglycerides

Ethical aspects

(mg / dl) and HbA1c (%) were taken from the most

Informed consent was requested from each of the

recent reports of the electronic le.

participants in order to be part of this research. The
international conventions contained in the Declaration
of Helsinki were respected.

Procedures
The survey was carried out in patients during their care
in the oﬃce, after applying informed consent. The

RESULTS

physical examination and ophthalmological evaluation

A total of 50 participants were included in the analysis;

were performed during this care. The rest of the

2% (n = 1) with type 1 DM, 48% with type 2 DM (n = 49).

examinations were collected from the medical records.

According to sex: 48% (n = 24) female and 52% (n = 26)

All data were collected once the participants had given

male. The mean age n (SD) was 58.7 (10.1) years. The
average age of duration of DM was 15 years. Average

their informed consent.

weight: 75 kg (16.1) Average height: 1.60 mtr. The DR

Statistic analysis

categories were as follows: Category 1: 24 (48.0%);

Statistical analyzes were done using the statistical

Category 2: 16 (32.0%); Category 3: 10 (20.0%) The mean

language R, version 4.0.3 (28). The categorical variables

duration of sleep (SD) was 7.94 hrs. 6% (n = 3), 40% (n =

were evaluated with Chi square and those numerical

20), 54% (n = 27) had short, normal, or long SD

with the Kruskal-Wallis test to compare the clinical and

respectively; the most frequent degree of education

demographic characteristics of the participants

was secondary 36% (n = 18); use of insulin in 32% (n =

between categories of interest. For variables with

16); present smoking 7.4% (n = 2); Average total

statistically signi cant diﬀerences, post-hoc analyzes

triglycerides: 257 [77.0, 1200 mg / dl] mg / dl. Average

were performed using the Wilcoxon paired rank test.

total cholesterol: 209 mg / dl [110.506 mg / dl]. Average

Subsequently, correlation analysis was carried out on

glycemia 170.5mg / dl [71.474 mg / dl]. Systolic blood

the numerical variables by Pearson's correlation

pressure: 131mmHg (19.2mmHg); diastolic blood

coeﬃcient and visualizations of the data distributions

pressure 78.0mmHg (12.2mmHg); Average HbA1c:

by severity of diabetic retinopathy and statistically

8.29% (2.76%) (Table 1).

Table 1. Clinical and demographic characteristics of the study participants
Total (N=50)
Age
arithmetic average

58.7 (10.1)

Median [Min, Max]

58.0 [26.0, 86.0]

Gender
Femenine

24 (48.0%)

Masculine

26 (52.0%)

Diabetes duration
Mean (SD)
Median [Min, Max]
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15.0 (9.00)
15.0 [1.00, 35.0]
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Total (N=50)
Insulin Use
Absent

34 (68.0%)

Present

16 (32.0%)

Weight
Mean (SD)
Median [Min, Max]

75.0 (16.1)
72.3 [49.0, 125]

Cholesterol
Mean (SD)
Median [Min, Max]
Missing

209 (65.2)
200 [110, 506]
5 (10.0%)

Triglycerides
Mean (SD)
Median [Min, Max]
Missing

257 (194)
199 [77.0, 1200]
8 (16.0%)

HbA1c
Mean (SD)
Median [Min, Max]
Missing

8.29 (2.76)
7.43 [4.30, 13.5]
18 (36.0%)

Height in Meters
Mean (SD)
Median [Min, Max]

1.60 (0.0864)
1.59 [1.43, 1.80]

Retinopathy grade
Category 1

24 (48,0%)

Category 2

16 (32,0%)

Category 3

10 (20,0%)

Blood.pressure.SYSTOLIC
Mean (SD)
Median [Min, Max]

131 (19.2)
130 [80.0, 180]

DIASTOLIC.arterial.pressure
Mean (SD)
Median [Min, Max]

Other previously reported procedures: Pterygium
r e s e c t i o n , c a t a r a c t s u r g e r y, a p p l i c a t i o n o f
antiangiogenics, Yag laser, Argon laser, vitrectomy.
Other added ocular conditions found: primary open
angle glaucoma, neovascular glaucoma, macular
edema, cataract, pterygium..........
Other non-ocular conditions reported: hemodialysis,

78.0 (12.2)
80.0 [50.0, 110]

peritoneal dialysis, heart disease and anemia.
Of the previous procedures reported and other added
ocular conditions mentioned did not present statistical
relevance in the initial examinations.
The clinical and demographic characteristics of the
study participants strati ed by sleep duration are
shown in Table 2.
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Table 2. Clinical and demographic characteristics of the study
participants strati ed by sleep duration
< 6h
(N=3)

6≤h<8
(N=20)

≥ 8h
(N=27)

pvalue

Feminine

1 (33.3%)

12 (60.0%)

11 (40.7%)

0.434

Male

2 (66.7%)

8 (40.0%)

16 (59.3%)

Gender

Age
Mean (SD)

62.0 (10.5)

59.5 (12.8)

57.9 (7.70)

Median [Min,
Max]

63.0 [51.0,
72.0]

55.5 [26.0,
86.0]

58.0 [43.0,
74.0]

5.00 (0)

6.60 (0.503)

9.26 (1.02)

5.00 [5.00,
5.00]

7.00 [6.00,
7.00]

9.00 [8.00,
11.0]

0.806

Hours of sleep
Mean (SD)
Median [Min,
Max]
Studies
Preparatory

2 (66.7%)

1 (5.0%)

6 (22.2%)

Secondary

1 (33.3%)

6 (30.0%)

10 (37.0%)

None

0 (0%)

1 (5.0%)

0 (0%)

Primary

0 (0%)

6 (30.0%)

5 (18.5%)

College

0 (0%)

6 (30.0%)

6 (22.2%)

Absent

3 (100%)

20 (100%)

25 (92.6%)

Present

0 (0%)

0 (0%)

2 (7.4%)

Mean (SD)

17.0 (6.25)

13.9 (9.08)

15.6 (9.36)

Median [Min,
Max]

15.0 [12.0,
24.0]

14.5 [1.00,
32.0]

15.0 [1.00,
35.0]

Absent

2 (66.7%)

12 (60.0%)

20 (74.1%)

Present

1 (33.3%)

8 (40.0%)

7 (25.9%)

Mean (SD)

65.2 (6.53)

75.2 (14.9)

76.0 (17.6)

Median [Min,
Max]

63.0 [60.0,
72.5]

74.0 [53.0,
116]

72.0 [49.0,
125]

143 (57.7)

174 (77.0)

190 (89.9)

110 [109, 210]

161 [71.0, 361]

191 [87.5, 474]

<0.001

0.208

Smoking
0.576

Duration of Diabetes
0.829

Insulin Use
0.72

Weight

Glycemia
Mean (SD)
Median [Min,
Max]
Cholesterol
Mean (SD)

50.0 (86.6)

206 (95.1)

190 (71.5)

0 [0, 150]

204 [0, 506]

200 [0, 337]

Mean (SD)

50.0 (86.6)

258 (254)

202 (154)

Median [Min,
Max]

0 [0, 150]

184 [0, 1200]

179 [0, 641]

4.73 (4.96)

4.05 (4.54)

6.30 (4.51)

4.30 [0, 9.90]

2.50 [0, 11.5]

6.20 [0, 13.5]

Median [Min,
Max]

0.471

0.52

0.0482

Triglycerides
0.12

HbA1c
Mean (SD)
Median [Min,
Max]
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Figure 1. Analysis of cholesterol values in relation to reported hours of sleep

It can be clearly seen that the statistically signi cant
diﬀerence is due to the fact that the subgroup that

reported sleeping less than 6 hours only contains 3
patients and of these only 1 has the Cholesterol value
present, so the signi cant diﬀerence is spurious (Fig. 1 ).

Table 3. Characteristics of the participants strati

ed by category of severity

of diabetic retinopathy
Category 1
(N=24)

Category 2
(N=16)

Category 3
(N=10)

pvalue

Feminine

15 (62.5%)

6 (37.5%)

3 (30.0%)

0.166

Male

9 (37.5%)

10 (62.5%)

7 (70.0%)

57.9 (10.3)

59.8 (9.70)

59.1 (10.9)

56.5 [26.0,
76.0]

59.0 [46.0,
86.0]

58.5 [43.0,
76.0]

8.08 (1.82)

7.75 (1.65)

7.90 (1.60)

8.00 [5.00,
11.0]

7.00 [5.00,
10.0]

8.50 [5.00,
10.0]

Gender

Age
Mean (SD)
Median [Min,
Max]

Hours of sleep
Mean (SD)
Median [Min, Max]

0.895

0.877
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Studies
Preparatory

5 (20.8%)

2 (12.5%)

2 (20.0%)

Primary

7 (29.2%)

3 (18.8%)

1 (10.0%)

Secondary

5 (20.8%)

8 (50.0%)

4 (40.0%)

college

7 (29.2%)

2 (12.5%)

3 (30.0%)

0 (0%)

1 (6.2%)

0 (0%)

Absent

23 (95.8%)

16 (100%)

9 (90.0%)

Present

1 (4.2%)

0 (0%)

1 (10.0%)

Mean (SD)

11.1 (7.59)

20.3 (8.41)

15.9 (9.23)

Median [Min,
Max]

8.50 [1.00,
26.0]

19.0 [3.00,
35.0]

16.0 [1.00,
35.0]

Absent

18 (75.0%)

9 (56.2%)

7 (70.0%)

Present

6 (25.0%)

7 (43.8%)

3 (30.0%)

Mean (SD)

75.9 (19.0)

73.8 (13.4)

74.6 (13.5)

Median [Min,
Max]

72.0 [49.0,
125]

73.8 [55.0,
94.0]

74.5 [56.0,
98.0]

167 (90.7)

206 (79.6)

171 (64.1)

128 [71.0, 474]

197 [82.0, 364]

140 [87.5, 257]

197 (47.3)

222 (91.5)

218 (57.6)

200 [110, 337]

211 [114, 506]

227 [113, 288]

1 (4.2%)

2 (12.5%)

2 (20.0%)

217 (133)

346 (291)

233 (123)

179 [77.0, 641]

263 [108,
1200]

200 [93.0, 413]

1 (4.2%)

4 (25.0%)

3 (30.0%)

Mean (SD)

8.06 (3.18)

9.44 (2.19)

6.75 (1.83)

Median [Min,
Max]

6.25 [4.30,
13.5]

9.90 [5.50,
12.4]

6.50 [5.00,
10.1]

Missing

9 (37.5%)

5 (31.2%)

4 (40.0%)

< 6h

1 (4.2%)

1 (6.2%)

1 (10.0%)

6≤h<8

9 (37.5%)

8 (50.0%)

3 (30.0%)

≥ 8h

14 (58.3%)

7 (43.8%)

6 (60.0%)

None

0.504

Smoking
0.691

Duration of
Diabetes
0.0091
7

Insulin Use
0.527

Weight

Glycemia
Mean (SD)
Median [Min, Max]

0.974

0.212

Cholesterol
Mean (SD)
Median [Min,
Max]
Missing

0.392

Triglycerides
Mean (SD)
Median [Min,
Max]
Missing

0.184

HbA1c
0.127

hours Range
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Figure 2. Post-hoc analysis of the severity categories of diabetic retinopathy
compared to the duration of diabetes

It can be seen that the statistically signi cant diﬀerence
is found in the pair represented by categories 1 and 2
with respect to the reported duration of diabetes.
The signi cant correlations are mentioned below:
Diastolic and Systolic Blood Pressure (0.429),

Triglycerides and Total Cholesterol (0.707), HbA1c and
Glycemia (0.561), ESS Score and Age (0.394), ESS Score
and Weight (0.365), Stop Bang and Age (0.317), Stop
Bang and Weight (0.579), Stop Bang and ESS Score
(0.452), ISI Score and Stop Bang (0.460) (Fig. 3).

Figure 3. Correlations between the numerical variables of the study.
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Figure 4. Distribution of global values of the Stop Bang Score (A), ISI Score (B) and ESS Score (C) by
category of severity of diabetic retinopathy strati ed by number of reported hours of sleep.
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As can be seen in Fig. 4A, with the data included in this
study, a relationship between the severity of diabetic
retinopathy, the reported hours of sleep and the global
Stop Bang score is not appreciated.
In the results, as with the Stop Bang score, with the data
included in this study, a relationship between the
severity of diabetic retinopathy, the reported hours of
sleep and the global ISI score is not appreciated (Fig. 4B).
Unlike the other two scores, in this case a trend towards
an elevation of the ESS score can be seen in the
subgroup of patients who reported sleeping 8 hours or
more (Fig. 4C), although the trend is not statistically
signi cant. consider that this nding is congruent with
the state of the art on the subject of sleep and metabolic
condition of retinopathy diabetic patients, it will be
necessary to explore this phenomenon in more detail
and in a greater number of patients.

DISCUSSION
For the purposes of our study: the quality and quantity
of sleep, indirectly evaluated by the daytime sleepiness
reported by the patients (ESS Score) shows a tendency
to rise in those who reported sleep ranges outside the
physiologically appropriate (≥ 8 hrs) , we can also nd
characteristics of the population consistent with the
clinical reality studied, such as the directly proportional
correlations between the reported serum levels of
triglycerides and total cholesterol, the HbA1c and
reported serum glycemia, the ESS score and age and
weight, the Stop score Bang and age and weight, the
Stop Bang score and the ESS score as well as the ISI score
and the Stop Bang. Despite the ndings in these
correlations, the numerical results are not consistent
with them, the authors consider that this phenomenon
is due to the limited population sample of the study.
Future work will seek to strengthen the size of the
population to improve the sample universe in order to
clarify the results.
Our study explores a clinical reality in Latin American

retinopathy diabetic patients consistent with the
scienti c literature that has explored and reported
similar ndings in populations from other geographic
regions in the world. Given that, up to the knowledge
that the authors have on the subject, this is the rst
study of these characteristics carried out in a speci c
Latin American population, it is striking that the trends
observed in the results are congruent with that
reported by other authors in other geographic regions.
worldwide.
Good control of blood glucose and other systemic risk
factors such as hypertension and hyperlipidemia are
the main objective for the prevention of ocular
complications in diabetes mellitus. The authors
consider it important to integrate the assessment of
sleep quality in the retinopathy diabetic patient to
strengthen the care strategy, in collaboration with
experts in lifestyle medicine. The data suggest that
optimization of the duration and quality of sleep should
be tested as an intervention to improve glucose control
in patients with type 2 diabetes.
The limitations of the study lie mainly in the small
sample size, which could limit the statistical power to
nd some associations. However, given the nature of
the study, the results are of great importance. As future
work, the authors propose to increase the sample size
signi cantly, as well as the subgroups in the same
representative of the intervals of reported hours of
sleep.

CONCLUSION
Although the trends are not statistically signi cant, the
authors consider that this nding is congruent with the
state of the art on the subject of sleep and metabolic
condition of retinopathic diabetic patients (trend of
elevated ESS score reported in the subgroup of 8 or
more hours of sleep ), it will be necessary to explore this
phenomenon in more detail and in a larger number of
patients.
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